Mr. Brian Pedlar reports

COVALON ANNOUNCES CONFERENCE CALL TO DISCUSS NEW COVAGUARD ANTIMICROBIAL TECHNOLOGY

Covalon Technologies Ltd. will hold a conference call to further discuss its new CovaGuard anti-microbial technology.

"We have received a positive response regarding our announcement about the new CovaGuard anti-microbial technology," said Brian Pedlar, President and Chief Executive Officer. "With the many business opportunities and queries about the technology that we have received, we have decided to hold a conference call to answer any questions that the public, the media, or our investors may have about CovaGuard."

The Company will hold a conference call on Monday, April 6, 2020, at 9 a.m. ET. To participate in the conference call, please dial one of the telephone numbers provided herein.

Toll-Free: 833.299.8117

Canada: 647.689.4535

Conference ID Code: 9767737

A recording of the call will be available by calling 855.859.2056 or 404.537.3406 and entering the conference ID code 9767737 from April 6th, 2020, at 12:00pm EST to April 20th, 2020, at 11:59pm EST. A recording of the call will also be available at the company's website.

About Covalon

Covalon Technologies Ltd. researches, develops, and commercializes new healthcare technologies that help save lives around the world. Covalon's patented technologies, products, and services address the advanced healthcare needs of medical device companies, healthcare providers, and individual consumers. Covalon's technologies are used to prevent, detect, and manage medical conditions in specialty areas such as infection control, vascular access, surgical procedures, advanced wound care, and medical device coatings.

We seek Safe Harbor.